Literature DB >> 8602779

Measurement of Goldmann visual fields in older children who received cryotherapy as infants for threshold retinopathy of prematurity.

G E Quinn1, D L Miller, J A Evans, W E Tasman, J A McNamara, D B Schaffer.   

Abstract

BACKGROUND: Cryotherapy administered to eyes with severe acute-phase (threshold) retinopathy of prematurity benefits retinal structure and visual acuity compared with the natural course of the retinopathy.
OBJECTIVES: To determine the extent of peripheral field abnormalities in eyes with threshold retinopathy of prematurity that had retinal structure preserved by cryotherapy.
METHODS: Kinetic perimetry was performed with a Goldmann perimeter by masked testers on patients in whom bilateral threshold retinopathy of prematurity developed and who had been randomly assigned to undergo cryotherapy in one eye and no cryotherapy in the fellow eye. With the V-4-e and the II-4-e targets, eight meridians were tested: 0 degrees, 45 degrees, 90 degrees, 135 degrees, 180 degrees, 225 degrees, 270 degrees, and 315 degrees. The median value of three presentations in each meridian was accepted as the extent in that meridian.
RESULTS: Fourteen eyes (eight treated and six control) of eight patients (mean age, 9.9 years; range, 6 to 11 years) had adequate vision to undergo fields testing. Mean (+/-SE) extent of visual field for treated vs control eyes was 36 degrees +/- 3 degrees vs 46 degrees +/- 6 degrees for the II-4-e target and 49 degrees +/- 4 degrees vs 59 degrees +/- 6 degrees for the V-4-e target. This difference was consistent across all eight meridians for either target, and repeated-measures analysis of variance showed that cryotherapy was associated with smaller visual field extent for both target sizes (P=.08).
CONCLUSION: The results of this small pilot study suggest that eyes that have retinal structure and acuity preserved by cryotherapy for severe acute-phase retinopathy of prematurity have slightly smaller visual fields than untreated eyes with severe acute-phase retinopathy of prematurity that had vision preserved.

Entities:  

Mesh:

Year:  1996        PMID: 8602779     DOI: 10.1001/archopht.1996.01100130421010

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Estrogen therapy to treat retinopathy in newborn mice.

Authors:  Wenjing Shi; L I Zhu; Yuhuan Wang; Baoyang Hu; Honglei Xiao; Guoming Zhou; Chao Chen
Journal:  Exp Ther Med       Date:  2015-06-05       Impact factor: 2.447

2.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

3.  Normal values for Octopus tendency oriented perimetry in children 7 through 13 years old.

Authors:  Sandra M Brown; Jay C Bradley; Matthias J Monhart; Deborah K Baker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

4.  Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations.

Authors:  Karina Paunescu; Bettina Wabbels; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-24       Impact factor: 3.117

5.  A case of retinopathy of prematurity treated by pattern scan laser photocoagulation.

Authors:  Satoshi Ota; Miho Nozaki; Shuichiro Hirahara; Tomoaki Hattori; Munenori Yoshida; Yuichiro Ogura
Journal:  Clin Ophthalmol       Date:  2014-07-29

6.  Development of a Pediatric Visual Field Test.

Authors:  Marco A Miranda; David B Henson; Cecilia Fenerty; Susmito Biswas; Tariq Aslam
Journal:  Transl Vis Sci Technol       Date:  2016-12-14       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.